MEDNAX (MD) Misses Q2 EPS by 1c

MEDNAX (NYSE: MD) reported Q2 EPS of $0.47, $0.01 worse than the analyst estimate of $0.48. Revenue for the quarter came in at $486 million versus the consensus estimate of $493.67 million.

For earnings history and earnings-related data on MEDNAX (MD) click here.

You May Also Be Interested In

• Piper Sandler sees Google TPU sales hitting $104BN by 2028
• Par Pacific names former Valero executive as refining and logistics chief
• ZoomInfo Technologies (GTM) PT Lowered to $4.25 at DA Davidson to Reflect Sector Headwinds